Research Portfolio

Funding Opportunities

Join our Mailing List
Join our mailing list to be notified of new funding opportunities.

Your Email

To receive information about funding opportunities, events, and program updates.

John Bielicki, Ph.D.

Lawrence Berkeley National Laboratory # of Grants: 3


Diagnostic tools of HDL damage by tobacco smoke 2000 (Cycle 9) $113,878
Cardiovascular Disease Inno Dev & Exp Awards (IDEAS)

Antiatherogenic helical segments of apo A-I 2004 (Cycle 13) $141,230
Cardiovascular Disease Inno Dev & Exp Awards (IDEAS)

Negative effects of smoke on novel HDL mimetic therapies 2008 (Cycle 17) $657,970
Cardiovascular Disease Research Project Awards

A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice.
Periodical: Journal of Lipid Research Index Medicus:
Authors: Bielicki JK, Zhang H, Cortez Y, Zheng Y, Narayanaswami V, Patel A, Johansson J, Azhar S ART
Yr: 2010 Vol: 51 Nbr: 20075422 Abs: Pg: 1496-1503

HDL Mimetic Peptide ATI-5261 Forms an Oligomeric Assembly in Solution That Dissociates to Monomers upon Dilution
Periodical: Biochemistry Index Medicus:
Authors: Zheng, Y., A. Patel , V. Narayanaswami, G. Hura, B. Hang, J.K. Bielicki ART
Yr: 2011 Vol: Nbr: 50 Abs: Pg: 4068-4076

The positional specificity of EXXK motifs within an amphipathic a-helix dictates preferential lysine_x000D_ modification by acrolein: implications for the design of high-density lipoprotein mimetic peptides
Periodical: Biochemistry Index Medicus:
Authors: Zheng, Y., S.H. Kim, A.B. Patel, V. Narayanaswami, A.T. Iavarone, G.L. Hura, and J.K. Biel ART
Yr: Vol: Nbr: Abs: Pg: PMID: 22800301